Concepedia

Leslie Tharenos

LT

Statistics

Publications

7

Citations

730

H-Index

7

Active since

2017

Affiliations

Takeda (Switzerland)(Current)

Anaheim Clinical Trials

Takeda (United States)

Los Angeles Clinical Trials

Catholic University of Korea

Leslie Tharenos is an author at Takeda (Switzerland) specializing in vaccine effectiveness, vaccine immunology, and vaccination.

Publications per year

2017–2024

7

Publications

7

Lasmiditan is an effective acute treatment for migraine

Bernice Kuca, Stephen D. Silberstein, Linda Wietecha et al. · Neurology · 2018 · 267 citations · Full text

, , +14

Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults

Sam Jackson, Joseph R. Lentino, James Kopp et al. · Vaccine · 2017 · 192 citations · Full text

, , +15

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Michael G. Ison, Alberto Papi, Eugene Athan et al. · Clinical Infectious Diseases · 2024 · 162 citations · Full text

, , +17

Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions

Robert G. Feldman, Raffaele Antonelli Incalzi, Katie Steenackers et al. · Clinical Infectious Diseases · 2023 · 52 citations · Full text

, , +17

Long-term efficacy and immunogenicity of Ad26.RSV.preF–RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study

Ann R. Falsey, Tessa Hosman, Arangassery Rosemary Bastian et al. · The Lancet Infectious Diseases · 2024 · 27 citations

, , +12

1–5 of 7